ReviewBreast cancer : basic and clinical research2023

Hormone Receptor-Positive / HER2-Negative Early Breast Cancer High-Risk Population: An Algorithm for Optimization Systemic Adjuvant Treatment Based on 2022 Updates.

Daniel González-Hurtado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.